GIRSCHWEILER THOMAS 4

Accession 0001437749-20-012378

CIK 0000834365other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 8:00 PM ET

Size

17.2 KB

Accession

0001437749-20-012378

Form 4

Period: 2019-01-17

Director

Transactions

Exercise of In-Money
Common Stock
2020-05-13$4.75/sh+1,544,194$7,334,922→ 2,916,825 total(indirect: By Taurus4757 GmbH)
Sale
Common Stock
2020-05-13$14.90/sh−492,277$7,334,927→ 2,424,548 total(indirect: By Taurus4757 GmbH)
Exercise/Conversion
Stock Option (Right to Buy)
2019-01-17−10,714→ 0 total
Exercise: $1.26From: 2010-02-27Exp: 2019-02-26→ Common Stock (10,714 underlying)
Exercise of In-Money
Warrants (Right to Buy)
2020-05-13−1,544,194→ 0 total(indirect: By Taurus4757 GmbH)
Exercise: $4.75From: 2014-03-25Exp: 2021-03-25→ Common Stock (1,544,194 underlying)
Exercise/Conversion
Common Stock
2019-01-17$1.26/sh+10,714$13,510→ 1,535,391 total(indirect: By Taurus4757 GmbH)
Sale
Common Stock
2019-10-04$15.36/sh−162,760$2,499,994→ 1,372,631 total(indirect: By Taurus4757 GmbH)
Sale
Common Stock
2020-05-22$10.50/sh−476,191$5,000,006→ 1,948,357 total(indirect: By Taurus4757 GmbH)

10% Owner

Transactions

Sale
Common Stock
2020-05-22$10.50/sh−476,191$5,000,006→ 1,948,357 total(indirect: By Taurus4757 GmbH)
Sale
Common Stock
2019-10-04$15.36/sh−162,760$2,499,994→ 1,372,631 total(indirect: By Taurus4757 GmbH)
Sale
Common Stock
2020-05-13$14.90/sh−492,277$7,334,927→ 2,424,548 total(indirect: By Taurus4757 GmbH)
Exercise/Conversion
Stock Option (Right to Buy)
2019-01-17−10,714→ 0 total
Exercise: $1.26From: 2010-02-27Exp: 2019-02-26→ Common Stock (10,714 underlying)
Exercise/Conversion
Common Stock
2019-01-17$1.26/sh+10,714$13,510→ 1,535,391 total(indirect: By Taurus4757 GmbH)
Exercise of In-Money
Common Stock
2020-05-13$4.75/sh+1,544,194$7,334,922→ 2,916,825 total(indirect: By Taurus4757 GmbH)
Exercise of In-Money
Warrants (Right to Buy)
2020-05-13−1,544,194→ 0 total(indirect: By Taurus4757 GmbH)
Exercise: $4.75From: 2014-03-25Exp: 2021-03-25→ Common Stock (1,544,194 underlying)

Footnotes (3)

[F1]The shares of common stock, par value $0.001 per share (the "Common Stock") were issued to Taurus457 GmbH ("Taurus"), an entity wholly owned by Thomas Girschweiler (together with Taurus, the "reporting person") a director and 10% shareholder of Biolife Solutions, Inc. (the "Company"), upon exercise of the warrants held by the reporting person.
[F2]On May 13, 2020, the reporting person exercised an in-the-money warrant to purchase 1,544,194 shares of Common Stock of the Company for $4.75 per share pursuant to Rule 16b-6 under the Securities Exchange Act of 1934, as amended. The reporting person exercised the warrant on a cashless basis pursuant to the terms of the warrant, resulting in the Company's withholding of 492,277 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 1,051,197 shares.
[F3]The warrants were issued to Taurus in March 2014 in connection with conversion of outstanding promissory notes and interest accrued thereon for units consisting of common stock and warrants.

Documents

1 file

BIOLIFE SOLUTIONS INC

CIK 0000834365

Entity typeother